199 related articles for article (PubMed ID: 22391564)
1. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma.
Boll K; Reiche K; Kasack K; Mörbt N; Kretzschmar AK; Tomm JM; Verhaegh G; Schalken J; von Bergen M; Horn F; Hackermüller J
Oncogene; 2013 Jan; 32(3):277-85. PubMed ID: 22391564
[TBL] [Abstract][Full Text] [Related]
2. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src.
Shi XB; Ma AH; Xue L; Li M; Nguyen HG; Yang JC; Tepper CG; Gandour-Edwards R; Evans CP; Kung HJ; deVere White RW
Cancer Res; 2015 Dec; 75(24):5309-17. PubMed ID: 26573802
[TBL] [Abstract][Full Text] [Related]
3. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
4. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
[TBL] [Abstract][Full Text] [Related]
6. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.
Wan X; Huang W; Yang S; Zhang Y; Zhang P; Kong Z; Li T; Wu H; Jing F; Li Y
Int J Biochem Cell Biol; 2016 Oct; 79():249-260. PubMed ID: 27594411
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
Gui B; Hsieh CL; Kantoff PW; Kibel AS; Jia L
PLoS One; 2017; 12(9):e0184166. PubMed ID: 28886115
[TBL] [Abstract][Full Text] [Related]
8. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
9. miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
Larne O; Hagman Z; Lilja H; Bjartell A; Edsjö A; Ceder Y
Carcinogenesis; 2015 Aug; 36(8):858-66. PubMed ID: 25969144
[TBL] [Abstract][Full Text] [Related]
10. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
11. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
[TBL] [Abstract][Full Text] [Related]
12. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
Meng D; Yang S; Wan X; Zhang Y; Huang W; Zhao P; Li T; Wang L; Huang Y; Li T; Li Y
Int J Biochem Cell Biol; 2016 Apr; 73():30-40. PubMed ID: 26827675
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
14. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
15. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
17. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
Xiao J; Gong AY; Eischeid AN; Chen D; Deng C; Young CY; Chen XM
Prostate; 2012 Oct; 72(14):1514-22. PubMed ID: 22314666
[TBL] [Abstract][Full Text] [Related]
18. A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.
Ding M; Lin B; Li T; Liu Y; Li Y; Zhou X; Miao M; Gu J; Pan H; Yang F; Li T; Liu XY; Li R
Oncotarget; 2015 Apr; 6(10):7686-700. PubMed ID: 25797256
[TBL] [Abstract][Full Text] [Related]
19. Anticancer function of microRNA-30e is mediated by negative regulation of HELLPAR, a noncoding macroRNA, and genes involved in ubiquitination and cell cycle progression in prostate cancer.
Ganapathy K; Ngo C; Andl T; Coppola D; Park J; Chakrabarti R
Mol Oncol; 2022 Aug; 16(16):2936-2958. PubMed ID: 35612714
[TBL] [Abstract][Full Text] [Related]
20. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
